Literature DB >> 25987011

Update knowledge on cervical cancer incidence and prevalence in Asia.

Muhammad Daniyal1, Naheed Akhtar, Saeed Ahmad, Urooj Fatima, Muhammad Akram, Hafiz Muhammad Asif.   

Abstract

Cervical cancer is the second most common cause of cancer-related death among women worldwide, with over 500,000 new cases diagnosed annually and 50% mortality rate in Asia. In the United States, approximately 10,370 new cases of cervical cancer are diagnosed annually, and estimated 3,710 deaths occur from the disease, making it the sixth most common cause of malignancy among American women. This study aims to provide awareness about cervical cancer as well as an updated knowledge about the prevalence and incidence of cervical cancer in Asia.

Entities:  

Mesh:

Year:  2015        PMID: 25987011     DOI: 10.7314/apjcp.2015.16.9.3617

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

1.  Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9.

Authors:  Nitesh K Kunda; Julianne Peabody; Lukai Zhai; Dominique N Price; Bryce Chackerian; Ebenezer Tumban; Pavan Muttil
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

2.  Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.

Authors:  Hongtu Cui; Ruilin Ma; Tao Hu; Gary Guishan Xiao; Chengjun Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

Review 3.  Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target.

Authors:  Maomao Wu; Yanxun Han; Xiangfei Gong; Ke Wan; Yuchen Liu; Yi Zhou; Lizhi Zhang; Guozheng Tang; Hui Fang; Bangjie Chen; Fan Yang; Qing Zhao; Genbao Wang; Chenghao Zhanghuang; Yunling Zhang
Journal:  Front Med (Lausanne)       Date:  2022-06-23

Review 4.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.

Authors:  Young Hun Chung; Hui Cai; Nicole F Steinmetz
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

5.  Trends in Cervical Cancer Mortality in Brazilian Women who are Screened and Not Screened.

Authors:  Adriana Cunha Vargas; Catia Dell Agnolo; Willian Augusto de Melo; Fernando Castilho Pelloso; Lander Dos Santos; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

6.  Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial-mesenchymal transition by suppressing the TGF-β/smad pathway via binding to GREM1.

Authors:  Hui Miao; Nuan Wang; Lin-Xin Shi; Zheng Wang; Wen-Bo Song
Journal:  Cancer Cell Int       Date:  2019-05-23       Impact factor: 5.722

7.  Effects of Notch Signaling Pathway in Cervical Cancer by Curcumin Mediated Photodynamic Therapy and Its Possible Mechanisms in Vitro and in Vivo.

Authors:  Guifang He; Tianlong Mu; Yali Yuan; Wenyan Yang; Yuan Zhang; Qingyun Chen; Meilu Bian; Yanshu Pan; Qing Xiang; Zhihua Chen; Aiping Sun
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

8.  Comparison of Diagnostic Methods in Detection of Squamous Cell Abnormalities in Iranian Women with Abnormal Pap's Smear Test and Associated Demographic and Issues.

Authors:  Fatemeh Samiee Rad; Mahdi Ghaebi; Simin Zarabadipour; Arezoo Bajelan; Fatemeh Pashazade; Mehri Kalhor; Amane Barikani
Journal:  Iran J Pathol       Date:  2020-02-19

9.  Knowledge, Perception, and Prevention Practices Related to Human Papillomavirus-based Cervical Cancer and Its Socioeconomic Correlates Among Women in Karachi, Pakistan.

Authors:  Lubna Riaz; Sana Manazir; Fatima Jawed; Shajeea Arshad Ali; Ramsha Riaz
Journal:  Cureus       Date:  2020-03-05

10.  Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.

Authors:  Hua Wang; Shu-Wei Li; Wei Li; Hong-Bing Cai
Journal:  Med Sci Monit       Date:  2019-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.